Overexpression of miR‑17‑5p protects against high glucose‑induced endothelial cell injury by targeting E2F1‑mediated suppression of autophagy and promotion of apoptosis

Yuan,Yifeng; Li,Xue; Li,Maoquan

doi:10.3892/ijmm.2018.3697

Overexpression of miR‑17‑5p protects against high glucose‑induced endothelial cell injury by targeting E2F1‑mediated suppression of autophagy and promotion of apoptosis

Authors:
- Yifeng Yuan
- Xue Li
- Maoquan Li
View Affiliations

Affiliations: Department of Interventional and Vascular Surgery, Tenth People's Hospital of Tongji University, Shanghai 200072, P.R. China, Department of Interventional and Vascular Surgery, Tenth People's Hospital of Tongji University, Shanghai 200072, P.R. China
Published online on: May 21, 2018 https://doi.org/10.3892/ijmm.2018.3697
Pages: 1559-1568

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

E2 promoter binding factor 1 (E2F1) has been reported to have an important regulatory role in cell survival during hyperglycemic conditions; however, the mechanisms remain to be fully elucidated. Bioinformatics analyses have suggested that microRNA (miR)‑17‑5p targets the 3'untranslated region (3'UTR) of E2F1. The aim of the present study was to characterize the protective effect of miR‑17‑5p/E2F1 on human umbilical vein endothelial cells (HUVECs) under high glucose (HG) conditions, to confirm the regulatory effect of miR‑17‑5p on E2F1/AMP‑activated protein kinase α2 (AMPKα2)‑mediated apoptosis and E2F1/mammalian target of rapamycin complex 1 (mTORC1)‑mediated autophagy. Bifluorescein experiments were performed to characterize the interaction between miR‑17‑5p and E2F1. The Cell Counting Kit‑8 assay, flow cytometry, immunofluorescence, and reverse transcription‑quantitative polymerase chain reaction and western blot analyses were used to detect cell viability, apoptosis, autophagy, and relative mRNA and protein expression, respectively. The results showed that HG induced the downregulation of miR‑17‑5p and upregulation of E2F1 during HUVEC injury. The downregulation of E2F1 inhibited HG‑induced HUVEC dysfunction by suppressing mTORC1‑mediated inhibition of autophagy and AMPKα2‑mediated promotion of apoptosis. The results suggested that inhibiting the expression of E2F1 protected against HG‑induced HUVEC injury via the activation of autophagy. The overexpression of miR‑17‑5p inhibited E2F1‑mediated HUVEC injury under HG conditions, which was reversed following transfection with an E2F1‑overexpression vector. The bifluorescein experiments showed that miR‑17‑5p targeted the 3'UTR of E2F1. Taken together, the results suggested that the expression of miR‑17‑5p inhibited HG‑induced endothelial cell injury by targeting E2F1.

View Figures

View References

1	Chao CL, Chuang CP, Cheng YF, Lee KR, Chang Y, Cheng SP, Chan WK and Ho FM: The protective role of autophagy in matrix metalloproteinase-mediated cell transmigration and cell death in high-glucose-treated endothelial cells. Inflammation. 39:830–838. 2016. View Article : Google Scholar : PubMed/NCBI
2	Weikel KA, Cacicedo JM, Ruderman NB and Ido Y: Knockdown of GSK3β increases basal autophagy and AMPK signalling in nutrient-laden human aortic endothelial cells. Biosci Rep. 36:pii: e00382. 2016. View Article : Google Scholar
3	Kang H, Ma X, Liu J, Fan Y and Deng X: High glucose-induced endothelial progenitor cell dysfunction. Diab Vasc Dis Res. 14:381–394. 2017. View Article : Google Scholar : PubMed/NCBI
4	Cam H and Dynlacht BD: Emerging roles for E2F: Beyond the G1/S transition and DNA replication. Cancer Cell. 3:311–316. 2003. View Article : Google Scholar : PubMed/NCBI
5	Lin Z, Ren N, Jiang Y, Xu W, Shi Y and Liu G: Adenovirus-mediated E2F-1 gene transfer augments gemcitabine-induced apoptosis in human colon cancer cells. Clin Lab. 61:1435–1444. 2015. View Article : Google Scholar : PubMed/NCBI
6	Zhang X, Liu G, Qiu J, Zhang N, Ding J and Hua K: E2F1-regulated long non-coding RNA RAD51-AS1 promotes cell cycle progression, inhibits apoptosis and predicts poor prognosis in epithelial ovarian cancer. Sci Rep. 7:44692017. View Article : Google Scholar : PubMed/NCBI
7	Wang Y, Zhou Y, Xiao L, Zheng S, Yan N and Chen D: E2f1 mediates high glucose-induced neuronal death in cultured mouse retinal explants. Cell Cycle. 16:1824–1834. 2017. View Article : Google Scholar : PubMed/NCBI
8	Wu Y, Ma S, Xia Y, Lu Y, Xiao S, Cao Y, Zhuang S, Tan X, Fu Q, Xie L, et al: Loss of GCN5 leads to increased neuronal apoptosis by upregulating E2F1- and Egr-1-dependent BH3-only protein Bim. Cell Death Dis. 8:e25702017. View Article : Google Scholar : PubMed/NCBI
9	Yang W, Park IJ, Yun H, Im DU, Ock S, Kim J, Seo SM, Shin HY, Viollet B, Kang I, et al: AMP-activated protein kinase α2 and E2F1 transcription factor mediate doxorubicin-induced cytotoxicity by forming a positive signal loop in mouse embryonic fibroblasts and non-carcinoma cells. J Biol Chem. 289:4839–4852. 2014. View Article : Google Scholar : PubMed/NCBI
10	Abdel Malik R, Zippel N, Frömel T, Heidler J, Zukunft S, Walzog B, Ansari N, Pampaloni F, Wingert S, Rieger MA, et al: AMP-activated protein kinase α2 in neutrophils regulates vascular repair via Hypoxia-inducible factor-1α and a network of proteins affecting metabolism and apoptosis. Circ Res. 120:99–109. 2017. View Article : Google Scholar :
11	Liu C, Liang B, Wang Q, Wu J and Zou MH: Activation of AMP-activated protein kinase alpha1 alleviates endothelial cell apoptosis by increasing the expression of anti-apoptotic proteins Bcl-2 and survivin. J Biol Chem. 285:15346–15355. 2010. View Article : Google Scholar : PubMed/NCBI
12	Real S, Meo-Evoli N, Espada L and Tauler A: E2F1 regulates cellular growth by mTORC1 signaling. PLoS One. 6:e161632011. View Article : Google Scholar : PubMed/NCBI
13	Meo-Evoli N, Almacellas E, Massucci FA, Gentilella A, Ambrosio S, Kozma SC, Thomas G and Tauler A: V-ATPase: A master effector of E2F1-mediated lysosomal trafficking, mTORC1 activation and autophagy. Oncotarget. 6:28057–28070. 2015. View Article : Google Scholar : PubMed/NCBI
14	Zhang Z, Zhang S, Wang Y, Yang M, Zhang N, Jin Z, Ding L, Jiang W, Yang J, Sun Z, et al: Autophagy inhibits high glucose induced cardiac microvascular endothelial cells apoptosis by mTOR signal pathway. Apoptosis. 22:1510–1523. 2017. View Article : Google Scholar : PubMed/NCBI
15	Bartel DP: MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell. 116:281–297. 2004. View Article : Google Scholar : PubMed/NCBI
16	Xu J, Wang Y, Tan X and Jing H: MicroRNAs in autophagy and their emerging roles in crosstalk with apoptosis. Autophagy. 8:873–882. 2012. View Article : Google Scholar : PubMed/NCBI
17	Zhai H, Fesler A and Ju J: MicroRNA: A third dimension in autophagy. Cell Cycle. 12:246–250. 2013. View Article : Google Scholar :
18	Han W, Fu X, Xie J, Meng Z, Gu Y, Wang X, Li L, Pan H and Huang W: MiR-26a enhances autophagy to protect against ethanol-induced acute liver injury. J Mol Med. 93:1045–1055. 2015. View Article : Google Scholar : PubMed/NCBI
19	Dong D, Fu N and Yang P: MiR-17 downregulation by high glucose stabilizes Thioredoxin-interacting protein and removes thioredoxin inhibition on ASK1 leading to apoptosis. Toxicol Sci. 150:84–96. 2016. View Article : Google Scholar :
20	Hajarnis S, Lakhia R, Yheskel M, Williams D, Sorourian M, Liu X, Aboudehen K, Zhang S, Kersjes K, Galasso R, et al: microRNA-17 family promotes polycystic kidney disease progression through modulation of mitochondrial metabolism. Nat Commun. 8:143952017. View Article : Google Scholar : PubMed/NCBI
21	Nandakumar P, Tin A, Grove ML, Ma J, Boerwinkle E, Coresh J and Chakravarti A: MicroRNAs in the miR-17 and miR-15 families are downregulated in chronic kidney disease with hypertension. PLoS One. 12:e01767342017. View Article : Google Scholar : PubMed/NCBI
22	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2^-ΔΔ^C^T method. Methods. 25:402–408. 2001. View Article : Google Scholar
23	Ladu S, Calvisi DF, Conner EA, Farina M, Factor VM and Thorgeirsson SS: E2F1 inhibits c-Myc-driven apoptosis via PIK3CA/Akt/mTOR and COX-2 in a mouse model of human liver cancer. Gastroenterology. 135:1322–1332. 2008. View Article : Google Scholar : PubMed/NCBI
24	Rezabakhsh A, Ahmadi M, Khaksar M, Montaseri A, Malekinejad H, Rahbarghazi R and Garjani A: Rapamycin inhibits oxidative/nitrosative stress and enhances angiogenesis in high glucose-treated human umbilical vein endothelial cells: Role of autophagy. Biomed Pharmacother. 93:885–894. 2017. View Article : Google Scholar : PubMed/NCBI
25	Zhu L, Wang G, Fischbach S and Xiao X: Suppression of microRNA-205-5p in human mesenchymal stem cells improves their therapeutic potential in treating diabetic foot disease. Oncotarget. 8:52294–52303. 2017.PubMed/NCBI
26	Reddy MA and Natarajan R: Targeting miR-200c to ameliorate diabetes-induced endothelial dysfunction. Diabetes. 65:1152–1154. 2016. View Article : Google Scholar : PubMed/NCBI
27	Kovesdi I, Reichel R and Nevins JR: E1A transcription induction: Enhanced binding of a factor to upstream promoter sequences. Science. 231:719–722. 1986. View Article : Google Scholar : PubMed/NCBI
28	Engelmann D and Pützer BM: The dark side of E2F1: In transit beyond apoptosis. Cancer Res. 72:571–575. 2012. View Article : Google Scholar : PubMed/NCBI
29	Wang P, Long M, Zhang S, Cheng Z, Zhao X, He F, Liu H and Ming L: Hypoxia inducible factor-1α regulates autophagy via the p27-E2F1 signaling pathway. Mol Med Rep. 16:2107–2112. 2017. View Article : Google Scholar : PubMed/NCBI
30	Korah J, Canaff L and Lebrun JJ: The retinoblastoma tumor suppressor protein (pRb)/E2 promoter binding factor 1 (E2F1) pathway as a novel mediator of TGFβ-induced autophagy. J Biol Chem. 291:2043–2054. 2016. View Article : Google Scholar
31	Fox MM, Phoenix KN, Kopsiaftis SG and Claffey KP: AMP-activated protein kinase α2 isoform suppression in primary breast cancer alters AMPK growth control and apoptotic signaling. Genes Cancer. 4:3–14. 2013. View Article : Google Scholar : PubMed/NCBI
32	Bartolomeo R, Cinque L, De Leonibus C, Forrester A, Salzano AC, Monfregola J, De Gennaro E, Nusco E, Azario I, Lanzara C, et al: mTORC1 hyperactivation arrests bone growth in lysosomal storage disorders by suppressing autophagy. J Clin Invest. 127:3717–3729. 2017. View Article : Google Scholar : PubMed/NCBI
33	Tan HW, Sim AY and Long YC: Glutamine metabolism regulates autophagy-dependent mTORC1 reactivation during amino acid starvation. Nat Commun. 8:3382017. View Article : Google Scholar : PubMed/NCBI
34	Lin C, Zhang M, Zhang Y, Yang K, Hu J, Si R, Zhang G, Gao B, Li X, Xu C, et al: Helix B surface peptide attenuates diabetic cardiomyopathy via AMPK-dependent autophagy. Biochem Biophys Res Commun. 482:665–671. 2017. View Article : Google Scholar
35	Zhang C, Hou B, Yu S, Chen Q, Zhang N and Li H: HGF alleviates high glucose-induced injury in podocytes by GSK3β inhibition and autophagy restoration. Biochim Biophys Acta. 1863:2690–2699. 2016. View Article : Google Scholar : PubMed/NCBI
36	O'Donnell KA, Wentzel EA, Zeller KI, Dang CV and Mendell JT: c-Myc-regulated microRNAs modulate E2F1 expression. Nature. 435:839–843. 2005. View Article : Google Scholar : PubMed/NCBI
37	Pickering MT, Stadler BM and Kowalik TF: miR-17 and miR-20a temper an E2F1-induced G1 checkpoint to regulate cell cycle progression. Oncogene. 28:140–145. 2009. View Article : Google Scholar :